Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Forst

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 5, 1999
Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitroT Kunt, T Forst, B Früh, et al.
Clinical Laboratory|June 15, 2000
Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitusA Pfützner, O Harzer, T Kunt, et al.
Diabetes, Obesity & Metabolism|January 4, 2007
The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weightT Schöndorf, T Forst, C Hohberg, et al.
International Journal of Molecular Medicine|December 19, 1998
Establishment of a quantitative RT-pCR for detection of vascular cell adhesion molecule-1 transcripts in endothelial cells after stimulation with advanced glycation endproductsT Kunt, T Forst, A Wilhelm, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 5, 2000
Serum levels of substance P are decreased in patients with type 1 diabetesT Kunt, T Forst, S Schmidt, et al.
European Journal of Endocrinology|May 25, 2011
Non-glycemic effects of insulin therapy: a comparison between insulin aspart and regular human insulin during two consecutive meals in patients with type 2 diabetesH Sourij, I Schmoelzer, A de Campo, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 3, 2005
Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetesT Forst, C Hohberg, S D Fuellert, et al.
Deutsche Medizinische Wochenschrift (1946)|February 22, 2000
[Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II]M Engelbach, T Kunt, P Kann, et al.
Atherosclerosis|June 26, 2007
Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery diseaseT Forst, E Karagiannis, G Lübben, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 24, 2004
IRIS II study: the IRIS II score--assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetesT Forst, E Standl, C Hohberg, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 5, 1999
Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitroT Kunt, T Forst, B Früh, et al.
Clinical Laboratory|June 15, 2000
Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitusA Pfützner, O Harzer, T Kunt, et al.
Diabetes, Obesity & Metabolism|January 4, 2007
The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weightT Schöndorf, T Forst, C Hohberg, et al.
International Journal of Molecular Medicine|December 19, 1998
Establishment of a quantitative RT-pCR for detection of vascular cell adhesion molecule-1 transcripts in endothelial cells after stimulation with advanced glycation endproductsT Kunt, T Forst, A Wilhelm, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 5, 2000
Serum levels of substance P are decreased in patients with type 1 diabetesT Kunt, T Forst, S Schmidt, et al.
European Journal of Endocrinology|May 25, 2011
Non-glycemic effects of insulin therapy: a comparison between insulin aspart and regular human insulin during two consecutive meals in patients with type 2 diabetesH Sourij, I Schmoelzer, A de Campo, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 3, 2005
Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetesT Forst, C Hohberg, S D Fuellert, et al.
Deutsche Medizinische Wochenschrift (1946)|February 22, 2000
[Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II]M Engelbach, T Kunt, P Kann, et al.
Atherosclerosis|June 26, 2007
Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery diseaseT Forst, E Karagiannis, G Lübben, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 24, 2004
IRIS II study: the IRIS II score--assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetesT Forst, E Standl, C Hohberg, et al.
Pageof 10